none title certification

UAB Pharma Nord Lithuania Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data
Financial report background

Financial statement report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
Working capital requirementinfo
Debt-to-equity ratioinfo
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2022
266,104
45,488
13,305
13,109
2,241
5.89
4.93
17,502
73,022
0
90,524
2023
352,698
80,341
28,184
22,308
5,082
9.02
6.32
39,810
91,754
8,081
122,858
2024
550,179
110,036
25,920
22,751
4,550
5.73
4.14
26,561
536,177
6,716
510,767
unlock data icon

Register and

explore Okredo data
unlock data icon

Register and

explore Okredo data

2024

Turnover (€)

550,179 €Ascended56 % *

Sales per employee (€)

110,036 €Ascended37 % *

Profit before tax (€)

25,920 €Descended-8 % *

Net Profit (€)

22,751 €Ascended2 % *

Profit per employee (€)

4,550 €Descended-10 % *

Total profitability (%)

5.73 %Descended-36.47 % *

Net profitability (%)

4.14 %Descended-34.49 % *

Equity (€)

26,561 €Descended-33 % *

Amounts Payable And Liabilities (€)

536,177 €Ascended484 % *

Non-current Assets (€)

6,716 €Descended-17 % *

CurrentAssets (€)

510,767 €Ascended316 % *

*over the last year starting selected period